<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00181</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> Section V&hyph;K. C. M. Collins, E. G. Hartley, and R. Pilsworth, The Prevention of  <!-- PJG 0012 frnewline --> Laboratory Acquired Infection, Public Health Laboratory Service, Monograph Series  <!-- PJG 0012 frnewline --> No. 6, 1974.  <!-- PJG 0012 frnewline --> Section V&hyph;L. Chatigny, M. A, ``Protection Against Infection in the Microbiological  <!-- PJG 0012 frnewline --> Laboratory: Devices and Procedures,'' in W.W. Umbreit (ed.), Advances in Applied  <!-- PJG 0012 frnewline --> Microbiology, Academic Press, New York, New York, 1961, 3:131&hyph;192.  <!-- PJG 0012 frnewline --> Section V&hyph;M.  Design Criteria for Viral Oncology Research Facilities, U.S. Department  <!-- PJG 0012 frnewline --> of Health, Education, and Welfare, Public Health Service, NIH, DHEW Publication  <!-- PJG 0012 frnewline --> No. (NIH) 75&hyph;891, 1975.  <!-- PJG 0012 frnewline --> Section V&hyph;N. Kuehne, R. W., Biological Containment Facility for Studying Infectious  <!-- PJG 0012 frnewline --> Disease, Appl. Microbiol. 26:239&hyph;243, 1973.  <!-- PJG 0012 frnewline --> Section V&hyph;O. Runkle, R. B., and G. B. Phillips, Microbial Containment Control  <!-- PJG 0012 frnewline --> Facilities, Van Nostrand Reinhold, New York, 1969.  <!-- PJG 0012 frnewline --> Section V&hyph;P. Chatigny, M. A., and D. I. Clinger, ``Contamination Control in  <!-- PJG 0012 frnewline --> Aerobiology,'' in R. L. Dimmick and A. B. Akers (eds.), An Introduction to  <!-- PJG 0012 frnewline --> Experimental Aerobiology, John Wiley &amp; Sons, New York, 1969, pp. 194&hyph;263.  <!-- PJG 0012 frnewline --> Section V&hyph;Q. As classified in the Third Report of the International Committee on  <!-- PJG 0012 frnewline --> Taxonomy of Viruses: Classification and Nomenclature of Viruses, R. E. F. Matthews  <!-- PJG 0012 frnewline --> (ed.), Intervirology 12 (129&hyph;296), 1979.  <!-- PJG 0012 frnewline --> Section V&hyph;R. A U.S. Department of Agriculture permit is required for the  <!-- PJG 0012 frnewline --> importation, interstate movement, and release into the environment of certain  <!-- PJG 0012 frnewline --> organisms that are plant or animal pathogens, whether genetically engineered or  <!-- PJG 0012 frnewline --> not. Permits are required for veterinary biologics and for certain plants or  <!-- PJG 0012 frnewline --> microorganisms derived through genetic engineering using genetic sequences from  <!-- PJG 0012 frnewline --> plant pests (pathogens). Specific information about regulated organisms and  <!-- PJG 0012 frnewline --> procedures for obtaining a permit for regulated organisms may be obtained from the  <!-- PJG 0012 frnewline --> Director, Biotechnology, Biologics, and Environmental Protection, Animal and Plant  <!-- PJG 0012 frnewline --> Health Inspection Service, U.S. Department of Agriculture, 6505 Belcrest Road,  <!-- PJG 0012 frnewline --> Room 850, Hyattsville, Maryland 20782, (301) 436&hyph;7601.  <!-- PJG 0012 frnewline --> Section V&hyph;S. i.e., the total of all genomes within a family shall not exceed two-thirds  <!-- PJG 0012 frnewline --> of the genome.  <!-- PJG 0012 frnewline --> Section V&hyph;T. All activities, including storage of variola and whitepox, are restricted  <!-- PJG 0012 frnewline --> to the single national facility (World Health Organization Collaborating Center for  <!-- PJG 0012 frnewline --> Smallpox Research, Centers for Disease Control and Prevention, Atlanta, Georgia).  <!-- PJG 0012 frnewline --> Section V&hyph;U. Human studies in which the induction or enhancement of an immune  <!-- PJG 0012 frnewline --> response to a vector-encoded microbial immunogen is the major goal, such an  <!-- PJG 0012 frnewline --> immune response has been demonstrated in model systems, and the persistence of  <!-- PJG 0012 frnewline --> the vector-encoded immunogen is not expected, are not covered under Sections  <!-- PJG 0012 frnewline --> III&hyph;A&hyph;2, III&hyph;B&hyph;2, or III&hyph;B&hyph;3. Such studies may be initiated without RAC review and  <!-- PJG 0012 frnewline --> NIH approval if approved by another Federal agency.  <!-- PJG 0012 frnewline --> Section V&hyph;V. For recombinant DNA experiments in which the intent is to modify  <!-- PJG 0012 frnewline --> stably the genome of cells of one or more human subjects (see Sections III&hyph;A&hyph;2, III&hyph;B&hyph;2, and III&hyph;B&hyph;3).  <!-- PJG 0012 frnewline --> Section V&hyph;W. In accordance with accepted scientific and regulatory practices of the  <!-- PJG 0012 frnewline --> discipline of plant pathology, an exotic plant pathogen (e.g., virus, bacteria, or  <!-- PJG 0012 frnewline --> fungus) is one that is unknown to occur within the U.S. (see Section V&hyph;R).  <!-- PJG 0012 frnewline --> Determination of whether a pathogen has a potential for serious detrimental impact  <!-- PJG 0012 frnewline --> on managed (agricultural, forest, grassland) or natural ecosystems should be made  <!-- PJG 0012 frnewline --> by the Principal Investigator and the Institutional Biosafety Committee, in  <!-- PJG 0012 frnewline --> consultation with scientists knowledgeable of plant diseases, crops, and ecosystems  <!-- PJG 0012 frnewline --> in the geographic area of the research.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Appendix A. Exemptions Under Section III&hyph;E&hyph;5_Sublists of  <!-- PJG 0012 frnewline --> Natural Exchangers  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            